New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For THLD;ISRG;GERN;NFLX;ZIOP;ONTY;HWD;XWES;TROX;MRO;HK;STRZA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | all recent news | >>
January 20, 2015
16:06 EDTNFLXNetflix sees Q1 EPS 60c, consensus 77c
Subscribe for More Information
16:06 EDTNFLXNetflix reports 4.33M members added in Q4
Subscribe for More Information
16:00 EDTNFLXOptions Update; January 20, 2015
iPath S&P 500 VIX Short-Term Futures down 36c to 35.12 Option volume leaders: AAPL TSLA TWTR GILD NFLX MGM ABX AMAT JNJ C according to Track Data.
15:21 EDTNFLXNotable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include IBM (IBM), consensus $5.41; Netflix (NFLX), consensus 45c; CA Technologies (CA), consensus 60c; Cree (CREE), consensus 22c; Woodward (WWD), consensus 46c; Fulton Financial (FULT), consensus 21c; Advanced Micro Devices (AMD), consensus 1c; Interactive Brokers (IBKR), consensus 6c; Pinnacle Financial (PNFP), consensus 53c.
14:17 EDTNFLXNetflix technical commentary ahead of earnings
The stock has been in a sideways consolidation pattern since a sharp downtrend began in October of last year. The approximate range has been a high at $350 and a low at $320. Breaks of either end of this range will be important determinants of the trend following earnings. A breakout above $350 would potentially reverse the current dominant downtrend. With over 8.5% of the trading float short, there could be substantial buy-to-cover pressure in the event of a positive surprise. Upside levels to watch above $350 would be at $357.95, $366.51, and $375.83. On an extreme positive surprise, the $380 area could be tested. If the news is negative, a break below the $320 area would likely lead to a resumption of the dominant downtrend. Support levels to watch would be at $310.25, $299.50, and $290.28. A breakdown below $300 would be long-term bearish for price, confirming a major top.
14:04 EDTNFLXNetflix January weekly 345 straddle priced for 11% movement into Q4
Subscribe for More Information
13:21 EDTZIOPCAR T-Cell therapy drug stocks down sharply following NY Times story
Shares of biotechnology companies that are developing chimeric antigen receptor T cells or CAR T therapy drugs are falling sharply after a New York Times story titled "Riding High, Biotech Firms Remain Wary." WHAT'S NEW: Over the weekend, the New York Times published the story that struck a cautionary tone on the CAR-T therapy drugs. In this form of cancer treatment the patients own immune system cells are genetically manipulated to battle tumors. The New York Times story noted that there were some notable outcomes in the treatment of leukemia and lymphoma with the CAR T treatments but highlighted that the "technique is still early in development and can cause severe side effects." WHAT'S NOTABLE. Early last week, Intrexon (XON) and its oncology partner, ZIOPHARM Oncology (ZIOP), announced an exclusive licensing agreement with The University of Texas MD Anderson Cancer Center, including an exclusive sub-licensing agreement through MD Anderson for intellectual property developed at the University of Minnesota for the development of non-viral adoptive cellular cancer immunotherapies. Both companies' shares were up sharply following the announcement ZIOPHARM was up around 55% and Intrexon up over 30% the day following the announcement. PRICE ACTION: Shares of drug companies in the space are sharply lower in midday trading, with ZIOPHARM Oncology and Kite Pharma (KITE) each down over 9%, Intrexon down almost 12%, and Bellicum Pharmaceutical (BLCM) and bluebird bio (BLUE) each down almost 5%. Reference Link
08:39 EDTHKHalcon Resources downgraded to Neutral from Buy at SunTrust
SunTrust downgraded Halcon Resources to Neutral to reflect a lower commodity price deck forecast, lack of hedges, and high leverage. Price target lowered to $1.50 from $7.
08:11 EDTNFLXNetflix volatility increases into Q4 and outlook
Subscribe for More Information
07:38 EDTSTRZAStarz upgraded to Overweight from Equal Weight at Morgan Stanley
Subscribe for More Information
07:32 EDTHKHalcon Resources downgraded to Hold from Buy at KLR Group
Price target $1.
06:30 EDTSTRZAStarz upgraded to Overweight from Equal Weight at Morgan Stanley
Subscribe for More Information
05:54 EDTZIOPStocks with implied volatility movement; ZIOP INVN
Subscribe for More Information
January 16, 2015
11:16 EDTNFLXCBS, Viacom climb following Stifel upgrades
Shares of CBS (CBS) and Viacom (VIA, VIAB) are climbing after research firm Stifel upgraded the stocks to Buy from Hold. CBS owns the CBS network and other entertainment properties. Viacom owns a number of cable networks, including MTV and Nickelodeon. WHAT'S NEW: CBS' NFL rights leave it well-positioned to charge cable companies and other TV providers high fees, Stifel analyst Benjamin Mogil wrote in a note to investors today. Meanwhile, the company's strong ratings and lower production costs reduce its risk, Mogil stated. CBS has more opportunities when it comes to selling its content to Internet TV networks such as Netflix (NFLX), Mogil believes. The analyst set a $65 price target on the shares. Meanwhile, Mogil believes that Viacom should benefit from the adoption of ratings measurements other than Nielsen's (NLSN) tools. Viacom has complained that Nielsen's tools have underestimated its ratings by failing to adequately take into account new types of content consumption, the analyst noted. Viacom's recent expansion into new international markets should also improve its performance, Mogil stated. He set an $89 price target on the shares. ANOTHER TO WATCH: Mogil initiated coverage of Twenty-First Century Fox (FOXA) with a $41 price target and Buy rating, saying that the company is well-positioned to benefit from its wide range of sports programming. He set a $41 price target on the shares. PRICE ACTION: In late morning trading, CBS advanced 2.75% to $55, Viacom gained 2.5% to $68, and Twenty-First Century Fox rose 0.4% to $34.72.
10:34 EDTNFLXNetflix January weekly volatility increases into Q4 and outlook
Netflix January weekly call option implied volatility is at 97, February is at 55, March is at 46; compared to its 26-week average of 37 according to Track Data, suggesting large near term price movement into the expected release of Q4 results on January 20.
10:14 EDTZIOPZiopharm mentioned cautiously by TheStreetSweeper blog
Subscribe for More Information
10:01 EDTNFLXOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:30 EDTNFLXNetflix results likely to beat expectations, says Cantor
Cantor expects Netflix's Q4 results to beat expectations. The firm views the company's 2015 original content as compelling and keeps a Buy rating on the shares.
08:57 EDTNFLXNetflix upgraded to Outperform at Cowen
Subscribe for More Information
06:09 EDTNFLXNetflix upgraded to Outperform from Market Perform at Cowen
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use